Cargando...
Management of rheumatic complications of immune checkpoint inhibitor therapy – an oncological perspective
Immune checkpoint inhibitors (CPIs) are an effective treatment for many cancers but cause diverse immune-related adverse events (IrAEs). Rheumatological IrAEs include arthralgia, arthritis, tenosynovitis, myositis, polymyalgia rheumatica and sicca syndrome. CPI use can unmask RA as well as causing f...
Gardado en:
| Publicado en: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900910/ https://ncbi.nlm.nih.gov/pubmed/31816079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez536 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|